KALY Announces A New Step Forward For Its Cannabis Extraction Lab
March 26 2019 - 1:15PM
InvestorsHub NewsWire
KALY Announces A New Step Forward
For Its Cannabis Extraction Lab
Dallas, TX -- March 26, 2019 --
InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc.
dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) today announced that the State of Texas plans
to remove hemp as a controlled substance next
week conjunction with the United States 2018 Farm Act is just the
type of market condition management is looking for to support the
implantation of the previously announced cannabis extraction lab to
be dedicated to the 100 acre hemp farm to be operated by partner
Nouveau (USOTC: NOUV) in Texas. KALY and NOUV plan to partner
on the development of a proprietary hemp cultivar dedicated to the
advancement of KALY’s pharmaceutical extract developments.
The continuing liberalization of cannabis laws such as the hemp
removal as a controlled substance in Texas, supports the work KALY
is advancing.
Last week, KALY published a research report on
the recent pilot treatment of Chronic
Obstructive Pulmonary Disease (COPD) in primates using an
extract derived from KALY’s patented cannabis extraction
process. The report details the study method and the
significance of the study. The report includes specific
findings and due to the substantial findings, the report includes
guidelines for next stage tests.
The full report can be read on the company’s
website at www.kali-extracts.com.
KALY is a health and wellness company set to
generate revenue from its patented cannabis extraction technology
through overlapping go-to-market strategies. In addition
developing pharmaceutical products internally and through
partnerships, KALY is utilizing is patented cannabis extraction
process to develop numerous wellness products both internally and
through partnerships. The first revenue generating contracts signed
in December of 2018 will be reflected in the company’s upcoming
annual report.
To learn more
about the company visit https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024